Kseniya Simpson
InvestorAnalyst at Hatteras Venture Partners
Raleigh-Durham / Southeast US
Writes $100K β $5M checks Β· typically $1.5M
Experience
- Hatteras Venture PartnersPartnercurrent2026 β present
- Hatteras Venture PartnersPrincipal2024 β 2026
- Hatteras Venture PartnersAssociate2022 β 2024
- Hatteras Venture PartnersSenior Analyst2021 β 2022
- Hatteras Venture PartnersAnalyst2019 β 2020Raleigh-Durham-Chapel Hill Area
- Incyclix BioBoard Directorcurrent2026 β presentDurham, North Carolina, United States
- Ribometrix Inc.Board Directorcurrent2025 β presentDurham, North Carolina, United States
- Sensorium TherapeuticsBoard Observercurrent2025 β presentBoston, Massachusetts, United States
- Ten63 TherapeuticsBoard Observercurrent2023 β presentDurham, North Carolina, United States
- Aer Therapeutics, Inc.Board Observercurrent2022 β presentRaleigh, North Carolina, United States
- Code BiotherapeuticsBoard Observercurrent2022 β presentHatfield, Pennsylvania, United States
- Trefoil TherapeuticsBoard Directorcurrent2025 β presentSan Diego, California, United States
- Trefoil TherapeuticsBoard Observer2022 β 2025San Diego, California, United States
- North Carolina Biosciences Organization (NCBIO)Board of Directorscurrent2021 β presentDurham, North Carolina, United States
- Vigil NeuroscienceBoard Observer2020 β 2022Cambridge, Massachusetts, United States
- Triangle Insights Group, LLCStrategy Consultant2017 β 2018Raleigh-Durham-Chapel Hill Area
- Triangle Insights Group, LLCAssociate Strategy Consultant2016 β 2017Raleigh-Durham-Chapel Hill Area
- The University of North Carolina at Chapel HillPostdoctoral Researcher2015Chapel Hill, North Carolina, United States
- Yale VenturesLicensing Intern2013 β 2015New Haven, CT
- Yale UniversityTeaching Fellow and Lecturer2011 β 2013New Haven, CT
Education
- Yale School of MedicinePhD, Cellular and Molecular Physiology2009 β 2015
- University of ChicagoBS, Chemistry; BS2005 β 2009
Same school
Also attended Yale School of Medicine23
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital PartnersStephen KnightPresident & Senior Managing Partner at F-Prime Capital Partners
+ 17 more
Also attended University of Chicago242
Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalJonas CiplickasPrincipal at Scale Venture PartnersJulia Gonzalez SandersPartner and General Counsel at Crosslink Capital
+ 236 more
Shared employers
Also worked at Ribometrix Inc.7
Phil GrayeskiManaging Partner at KdT VenturesJeffrey MoorePresident at MC Healthcare VenturesHakan GokerManaging Director at M VenturesChristian SchubertHead of AbbVie Ventures at AbbVieWouter MeulemanPartner at Illumina VenturesShawna FrazierDirector at AbbVie
+ 1 more
Also worked at Ten63 Therapeutics1
Also worked at Yale Ventures5
Colleagues at Hatteras Venture Partners
Alston Gardner
Special Advisor at Hatteras Venture Partners
Ben Scruggs
Partner at Hatteras Venture Partners
Ben Scruggs, PhD
Partner at Hatteras Venture Partners
Christy Shaffer
General Partner at Hatteras Venture Partners
Christy Shaffer, PhD
General Partner at Hatteras Venture Partners
Clay Thorp
General Partner at Hatteras Venture Partners
Declan Devens
Operations Analyst at Hatteras Venture Partners
Don Rose
Venture Partner at Hatteras Venture Partners


























%20(1).png)






